Adam Bisaga

Adam Bisaga is a prominent academic figure at Columbia University, where they contribute to the Psychiatry through intensive research in Opioid Use Disorder, Medication-Assisted Treatment, Naltrexone, Buprenorphine, Ketamine, Neurotransmitter Receptors, Telehealth, Clinical Trials. A representative example of their recent contribution is the study titled "Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk", which offers critical insights into the dynamics of Opioid Use Disorder and Medication-Assisted Treatment. Additional work such as "Telehealth for opioid use disorder: retention as a function of demographics and rurality" further demonstrates their commitment to advancing knowledge in this domain.